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Blue toe syndrome (BTS) is a condition charac-
terized by the blue or violaceous discoloration of one
or more toes as a result of tissue ischemia. First
described in 1976 in a report of 31 patients who
presented with cyanotic toes secondary to embolic
phenomena, it has since been linked with several
different diseases including embolic, thrombotic,
infectious and vasoconstrictive disorders.1,2 Three
fundamental mechanisms are thought to underlie the
alteration in skin color: diminished arterial perfusion,
impaired venous outflow, and abnormal circulating
blood.1 Here we report an unusual case of leukemia
cutis secondary to chronic lymphocytic leukemia
manifesting as blue toe syndrome in the absence of
background cryoglobulinemia or cold agglutinin
disease.CASE REPORT
A 74-year-old white man with a medical history
significant for coronary artery disease, basal cell
carcinoma, squamous cell carcinoma, melanoma,
and chronic lymphocytic leukemia (CLL) diagnosed
10 years prior presented for evaluation of bilateral
discoloration of the toes. Over the course of
6 months, the lesions had become increasingly
painful and intermittently edematous and had
darkened to a bluish color. On initial examination,
his toes were cool to the touch, and palpable
purpura with necrotic centers were observed on
the left and right dorsal great toes, second toes, third
toes, and fourth toes. The toes also had bulbous
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32757. E-mail: cinnamark@gmail.com.toe was the most discolored and had an additional
ulcerative exophytic plaque (Fig 1). The patient
otherwise denied fever, chills, night sweats, or
unintentional weight loss. No splenomegaly or
hepatomegaly was appreciated, and no palpable
lymphadenopathy in the anterior neck, supraclavic-
ular, axillary, or inguinal areas was present.
Results of computed tomography angiogram and
photoplethysmogram showed no significant athero-
sclerotic occlusive disease or thromboembolic source.
On further evaluation, a completebloodcount founda
normal differential with the exception of an elevated
absolute lymphocyte count of 4543 cells per microliter
(reference range, 850e3900 cells per microliter).
Serum rheumatoid factor, antinuclear antibody, cry-
ofibrinogen, and cryoglobulin were negative, and
there was no evidence of cold agglutinin disease.
Results of a serum protein electrophoresis,
urinalysis, and comprehensive metabolic panel
were unremarkable. Kappa/lambda light chain assay
showed a total serum kappa concentration of
194 mg/dL (reference range, 74e295 mg/dL),
total serum lambda concentration of 114 mg/dL
(reference range, 32e156 mg/dL), and a kappa/
lambda ratio of 1.7 (reference range, 1.3e2.7).
On immunohistochemical and microscopic
analysis, sections from a punch biopsy measuring
0.3 3 0.3 3 0.1 cm of the palpable purpura locatedJAAD Case Reports 2016;2:186-8.
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Fig 1. Leukemia cutis. Bluish discoloration and bulbous
swelling of the right toes. An ulcerative exophytic plaque
on the lateral aspect of the second toe.
Fig 2. Leukemia cutis. Punch biopsy of the palpable pur-
pura located on the right distal plantar great toe measuring
0.33 0.33 0.1 cm found a dense and diffuse infiltrate of the
dermis and endothelium of some vessel walls by small- to
medium-sized lymphoid cells, a picture consistent with CLL-
induced leukemia cutis. The epidermis is notably intact. (A
and B, hematoxylin-eosin stain; A, low-power magnifica-
tion; B, high-power magnification.). A high-resolution
version of this slide for use with the Virtual Microscope is
available as eSlide: VM02580 and eSlide: VM02582.
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and diffuse infiltrate of the dermis and endothelium
of some vessel walls by small- to medium-sized
lymphoid cells along with an intact epidermis (Fig 2).
The cells were CD201, CD79A1, CD431, CD51,
CD10e, CD138e, CD451, CD34e, and CD231
B cells. The CD20 staining was mild to moderate,
labeling more than 80% of the cells. CD34 staining
found prominent vascularity and notable thick-
walled vessels with fibrinoid change around them.
In view of the history of chronic lymphocytic
leukemia, this infiltrate is consistent with leukemic
infiltration. However, the clinical picture (6 months
of blue toes) and lack of vasculopathy is unusual.
Because the biopsy results indicated CLL involve-
ment of the skin, focal radiation therapy was
recommended.
Eighteen days after radiation therapy, the patient
was seen for follow-up and reported that his feet
were feeling finewith only minimal tenderness in the
distal toes of the left foot.
Physical examination did not find any further
complications, infection, or discoloration, and his
toes appeared to be healing well with no sign of
relapsed CLL.
DISCUSSION
This case of blue toe syndrome in our patient with
a 10-year history of CLL proves unusual, as leukemia
cutis has yet to be reported as an etiology of blue
toes. Because the pathophysiology of blue toe
syndrome typically centers on dysfunction of arterial
perfusion, venous outflow, and blood circulation, it
is not entirely surprising that a hematologic
malignancy such as CLL could be an inciting factor
in the development of blue toes. Although other
hematologic malignancies are typically more
associated with coagulopathy, CLL has been found
to confer as much as a 10-fold increase in the risk ofvenous thromboembolism, with reports of deep
venous thromboembolism, pulmonary embolism,
and even thrombosis of the common femoral
vein.3,4 Pathophysiology of the thrombotic phenom-
enon in CLL is likely an extension of leukemic
infiltration into involved vasculature, as monoclonal
infiltration of B lymphocytes was noted in all 42
patients with cutaneous infiltrates by Cerroni et al,5
and hyperleukocytosis is reported in a case of
CLL-induced femoral thrombosis by Cukierman
et al.4
Because such a hypercoagulable state is known to
exist in hematologic malignancies such as CLL, and
because of the proposed pathogenic mechanisms
of blue toe syndrome, it would be reasonable
to attribute our patient’s toe discoloration to
vaso-occlusive disease.6 Interestingly, however, our
patient exhibited no such signs of thromboembolic
disease, and laboratory testing found no indication
of an underlying hypercoagulable state.
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initially suggested a vaso-occlusive process of other
etiologies, the negative vascular and autoimmune
workup, as well as the definitive biopsy showing
leukemic infiltrate into the dermis and vasculature,
confirmed that our patient’s presentation of blue toes
was secondary to CLL-induced leukemia cutis. The
resolution of symptoms with radiation therapy
further suggested that the blue toe discoloration
was directly attributable to the presence of leukemic
cells within the vascular endothelium and dermis.
Additionally, although the exophytic plaque located
on the patient’s right second toe was not biopsied,
we presume that this was part of the same process, as
it initially began as a purpuric papule before
ulcerating. It also promptly resolved with the
radiation treatment.
This case shows the importance of considering a
leukemic process in a patient presenting with
blue/purple toes in the background of a CLLdiagnosis, as timely recognition and administration
of proper therapy can allow resolution of symptoms
without further vascular sequelae.
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